New diabetes QOF indicators recommended by NICE
An update of the QOF indicator list by NICE suggests that eight new diabetes indicators should be added to QOF from 2019/20. NICE says that the new approach, which comes following a review of the QOF in England, will improve outcomes and decrease the risk of harm from over-treatment.
Professor Gillian Leng, Deputy Chief Executive of NICE, said: “A number of the new NICE indicators for people with diabetes take account of frailty and are a step towards helping enable the greater personalisation of care. The intent of these indicators is to reduce the risk of treatment-related harm and improve the quality of life for people with moderate or severe frailty.”
Updated indicators on type 2 diabetes include two indicators on blood glucose targets for people with and without frailty, while another sets one blood pressure target for all people without frailty. Meanwhile, three new indicators feature which have been added since the consultation draft, supporting existing NICE recommendations on cardiovascular risk assessments and statin treatment for people with type 2 diabetes.
The QOF menu is used as part of GP contract negotiations, where the GPC and NHS England make final decisions about the final QOF list.
The new indicators are:
The full list of NICE’s proposed indicators can be found at: https://www.nice.org.uk/standards-and-indicators/qofindicators
READ MORE ARTICLES